ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK 2180 CE (CALL) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

Live Options price premium & chart analysis for GLENMARK 2180 CE (CALL) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited GLENMARK trades in NSE under Pharmaceuticals NSE

GLENMARK 2180 CE Live prices

What is premium price of GLENMARK 2180 CE CALL today?
Premium of GLENMARK 2180 CE is 12.30 on 29 Dec 2025 CALL opened at 11.00 and traded inside a Low-High range of 10.95-14.30 today. Please click here table for more current prices.
What is open interest of GLENMARK 2180 CALL CE today?
Open Interest of GLENMARK 2180 CE is 9750 today. This has changed 1500.00 from previous day.
What is underlying price of GLENMARK 2180 CE CALL today?
Underlying price of GLENMARK 2180 CE CALL is 2009.60 today.
What is lot size of GLENMARK 2180 CALL CE today?
Lot size of GLENMARK 2180 CALL CE is 375.00
Is GLENMARK 2180 CE CALL ITM or OTM or ATM?
GLENMARK 2180 CALL CE is OTM CALL option (out of the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Underlying equity prev closing: 2009.70

GLENMARK CALL CE available options strikes

CE 1920, CE 1940, CE 1960, CE 1980, CE 2000, CE 2020, CE 2040, CE 2060, CE 2080, CE 2100, All CE , All PE

GLENMARK 2180 CALL CE available expiry dates

27 Jan 202624 Feb 2026

Premium of GLENMARK 2180 CALL CE January 27 2026

GLENMARK 2180 CE Live prices

Premium of CALL (CE) of strike 2180 is at: 12.30 on 29 Dec 2025
CALL opened at 11.00 and traded inside a Low-High range of 10.95-14.30 as on 29 Mon Dec 2025

The underlying equity is trading at 2009.70 which means that CALL of strike 2180 is OTM CALL option (out of the money)

Lot size of GLENMARK Glenmark Pharmaceuticals Limited is 375

Total Open Interest for CALL (CE) of strike 2180 is 9,750

Munafa analysis GLENMARK 2180 CE might not be profitable for buyers to buy this CALL, but this could be a good opportunity for sellers to make a quick profit.

Price action analysis of 2180 CALL based on a short term time period is neutral. A longer time frame might give a better analysis.

Price action analysis of 2180 CALL based on a short term time period is neutral. A longer time frame might give a better analysis.

Click here to view most profitable CE and PE for Glenmark Pharmaceuticals Limited, both for buyers and sellers | GLENMARK Most Active Call Put Options

Date Underlying price CE price CE open CE high CE low CE volume CE OI OI Change
29 Mon Dec 2009.70 12.30 11.00 14.30 10.95 -5 3,656,250 18.2%
26 Fri Dec 2010.60 12.95 11.95 12.95 11.95 -17 3,093,750 4.8%
24 Wed Dec 2020.10 15.75 15.80 15.80 15.75 -37 2,953,125 31.3%
23 Tue Dec 2047.00 25.35 27.25 36.25 24.15 74 2,250,000 700%
22 Mon Dec 2038.20 14.50 0.00 0.00 0.00 0 281,250 0%
19 Fri Dec 1992.10 14.50 0.00 0.00 0.00 0 281,250 0%

Charts for GLENMARK 2180 CALL CE options for Glenmark Pharmaceuticals Limited

Select an expiry and a strike price below to view charts for those options. GLENMARK All in One charts

Charts for:      

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

GLENMARK 2180 CE (CALL) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

GLENMARK further analysis

GLENMARK 2180 CE (CALL) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

These are GLENMARK 2180 CE (CALL) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited . Click the links below to switch between charts

 

Videos related to: GLENMARK 2180 CE (CALL) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Using Candle Stick Charts Analysis

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

GLENMARK 2180 CE (CALL) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

 

Back to top